Roche Signs Epigenomics for Cancer Diagnostic, Prognostic Collaboration | GenomeWeb

NEW YORK, March 18 - Roche and Epigenomics announced today a three-year collaboration to develop molecular diagnostic and pharmacagenomic assays for cancer that use Epigenomics' DNA methylation technologies.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.